<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02487680</url>
  </required_header>
  <id_info>
    <org_study_id>DoubleGood Lund</org_study_id>
    <nct_id>NCT02487680</nct_id>
  </id_info>
  <brief_title>Effects of an Amino Acid and Chromium-picolinate Containing Drink on Glucose Metabolism on Healthy Subjects</brief_title>
  <official_title>Effect of a Table Water Enriched With Amino Acids and Chromium on Blood Glucose and Insulin Levels After a Meal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DoubleGood AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>DoubleGood AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has previously been shown in healthy overweight subjects, that table water including a&#xD;
      defined amount of amino acids and chromium can decrease the postprandial glucose. In this&#xD;
      study, the effect of this table water on glucose excursions after a test meal containing a&#xD;
      defined amount of available carbohydrates, protein and fat will be studied in healthy&#xD;
      subjects. The study will be conducted in a cross -over design, double blinded and placebo&#xD;
      controlled including 20 participants. The primary endpoint of the study is the incremental&#xD;
      area under the curve for plasma glucose (iAUCgluc) within 180 minutes after ingestion of the&#xD;
      meal.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the curve for Glucose after ingestion of a test meal</measure>
    <time_frame>180 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Area under the curve for insulin after ingestion of a test meal</measure>
    <time_frame>180 min</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Breakfast meal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A breakfast like meal will be provided together with a drink to overnight fasted subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lunch meal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A lunch like meal will be provided together with a drink to overnight fasted subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Amino Acids and chromium-picolinate containing drink</intervention_name>
    <description>Evaluation of the dietary supplement drink containing amino acids and chromium picolinate and aroma</description>
    <arm_group_label>Breakfast meal</arm_group_label>
    <arm_group_label>Lunch meal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo drink</intervention_name>
    <description>Evaluation of the placebo supplement drink containing only aroma</description>
    <arm_group_label>Breakfast meal</arm_group_label>
    <arm_group_label>Lunch meal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Stable body weight (no changes above 3 kg during the last 2 months)&#xD;
&#xD;
          -  Good general health&#xD;
&#xD;
          -  Body mass index 19 - 30 kg/m2 (normal to overweight)&#xD;
&#xD;
          -  Fasting blood glucose below 6.1 mmol/L&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any medication that could influence the study. Such as medication against diabetes,&#xD;
             hypoglycemia, hypertension or hypercholesterolemia&#xD;
&#xD;
          -  Psychiatric Disease&#xD;
&#xD;
          -  Alcohol or drug abuse&#xD;
&#xD;
          -  Smokers or people consuming snus&#xD;
&#xD;
          -  Acute infections&#xD;
&#xD;
          -  Vegetarians/vegans&#xD;
&#xD;
          -  Suffering from Lactose or Gluten intolerance&#xD;
&#xD;
          -  Pregnancy or Lactation&#xD;
&#xD;
          -  Participation in another study at the same time&#xD;
&#xD;
          -  Any other parameter that the PI will judge as inadequate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per Humpert, MD, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stoffwechselzentrum Rhein Pfalts, Mannheim, Germany and Department of internal medicine, University of Heidelberg, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ana Rasc√≥n, PhD, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Food for Health Science Center, Lund University, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kristina Andersson, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Experimental Medical Science, Lund University, Sweden</affiliation>
  </overall_official>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>June 29, 2015</study_first_submitted>
  <study_first_submitted_qc>June 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2015</study_first_posted>
  <last_update_submitted>May 11, 2017</last_update_submitted>
  <last_update_submitted_qc>May 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chromium</mesh_term>
    <mesh_term>Picolinic acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

